Alfresa Holdings logo

Alfresa Holdings

Asia, Tokyo, Japan, Tokyo

Description

Alfresa deals with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices.

Investor Profile

Alfresa Holdings has made 2 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • Japan (100%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Emergency Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alfresa Holdings frequently co-invest with?

Japan Lifeline
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Dai-ichi Life
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Co-Investments: 1
Sony Innovation Fund
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MAKOTO Capital
Asia, Miyagi, Japan, Sendai
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
KSP
Asia, Kanagawa, Japan, Kawasaki
Co-Investments: 1

What are some of recent deals done by Alfresa Holdings?

Gexval

Fujisawa, Kanagawa, Japan

Gexval is a healthcare firm that help patients and families fighting against orphan and intractable diseases.

Emergency MedicineHealth CareMedical
Series CJan 16, 2025
Amount Raised: $1,930,872
Metcela

Kawasaki, Kanagawa, Japan

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

BiotechnologyHealth CareMedical
Series BJan 4, 2021
Amount Raised: $12,700,000